Business · 13/08/2021Updated: 10/17/2026 · 1 min read
FDA Establishes Public Docket for Post-Approval Drug Regulation Comments
Summary
The FDA is seeking public input on post-approval regulation of certain pre-Hatch-Waxman drug products approved in abbreviated applications, which were previously overseen by the Office of Generic Drugs.